Please complete the CAPTCHA to continue
@regeneron.com
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
David Lederer is listed as Executive Medical Director ★ Strategy, Design & Execution of all Phases of Therapeutics Development at Regeneron, based in Tarrytown, New York, United States. AeroLeads shows a work email signal at regeneron.com and a matched LinkedIn profile for David Lederer.
David Lederer previously worked as Executive Medical Director, Genetic Medicines | Early Clinical Development at Regeneron and Senior Medical Director, Clinical Sciences, Immunology & Inflammation at Regeneron. David Lederer holds Master Of Science - Ms, Biostatistics from Columbia University.
This section adds company-level context without repeating David Lederer's masked contact details.
AeroLeads found 1 current-domain work email signal for David Lederer. Compare company email patterns before reaching out.
I am a mission-driven drug developer and former academic expert in pulmonary fibrosis and lung transplantation. I build and manage best-in-bred teams to develop transformative therapeutics to improve the lives of patients living with respiratory, fibrotic, immunological, and inflammatory diseases. I define innovative strategies to move a portfolio of drug candidates into early- and late-stage development and global registration, through to commercialization. I define and execute clinical development plans, including study design, protocol development, data analysis and interpretation, ensuring studies align with corporate and R&D objectives, are scientifically sound, uphold high ethical standards, and protect the safety of patients. I possess an extensive background in clinical research. I led NIH funded clinical and epidemiological research studies in interstitial lung disease and lung transplantation. As a key opinion leader in IPF, I participated in numerous clinical trial steering committees. I am a former standing member on the FDA Pulmonary-Allergy Drug Advisory Committee. I have authored 200+ peer-reviewed publications.
Listed skills include Clinical Research, Medicine, Epidemiology, Medical Education, and 19 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Tarrytown, New York, US
Currently, I'm the Senior Physician, Global Program Head and Clinical Development Lead for Regeneron’s siRNA NASH portfolio. Global strategist for 3 early clinical development programs in the NASH portfolio. Manage Medical Directors/Senior Medical Directors and guide cross-functional teams in clinical programs. Prior to corporate restructuring in 2023.
Tarrytown, New York, US
I advanced to global clinical lead for the Phase 3 itepekimab development program in COPD. Served as respiratory clinical expert for the dupilumab clinical development program (COPD, asthma, allergic bronchopulmonary aspergillosis). Partnered with Alliance Partner for sBLA dossier preparation/submissions (dupilumab pediatric asthma & eosinophilic.
Tarrytown, New York, US
In 2019, I transitioned to the biotechnology industry to lead clinical development with an emphasis on respiratory therapeutics. Directed clinical strategy, study design and medical monitoring of respiratory and COVID clinical studies (Phase 2 dupilumab for allergic bronchopulmonary aspergillosis & Phase 2/3 sarilumab for COVID-19).Selected Achievements.
Chicago, IL, US
During my time as a practicing Physician, I was enlisted to serve on the 4-member executive medical team for this non-profit organization focused on raising awareness, providing disease education, and driving pulmonary research. Oversaw Interstitial Lung Disease (ILD) programs across 60 US medical centers. Articulated foundation mission and goals with.
New York, NY, US
Contributed to this society medical journal as editorial lead of a 50-member team that edits and publishes clinical trials, original research, ATS documents, systematic reviews, and case conferences in clinical, epidemiological, and health services research related to adult and pediatric pulmonary, respiratory, critical care medicine, sleep, and population.
New York, New York, US
Throughout my prestigious career as a Pulmonologist, I honed my expertise in Interstitial Lung Disease (ILD) and lung transplantation. PI of multiple NIH R01 grants, funded clinical and epidemiological studies in idiopathic pulmonary fibrosis, interstitial lung disease and lung transplantation. Served as Founder & Director of the Pulmonary & Intensive Care.
New York, New York, US
Quick answers generated from the profile data available on this page.
David Lederer works for Regeneron.
David Lederer is listed as Executive Medical Director ★ Strategy, Design & Execution of all Phases of Therapeutics Development at Regeneron.
AeroLeads has found 1 work email signal at @regeneron.com for David Lederer at Regeneron.
David Lederer is based in Tarrytown, New York, United States while working with Regeneron.
David Lederer has worked for Regeneron, Pulmonary Fibrosis Foundation, American Thoracic Society, and Columbia University Irving Medical Center.
You can use AeroLeads to view verified contact signals for David Lederer at Regeneron, including work email, phone, and LinkedIn data when available.
David Lederer holds Master Of Science - Ms, Biostatistics from Columbia University.
David Lederer is listed with skills including Clinical Research, Medicine, Epidemiology, Medical Education, Critical Care, Lung, Public Health, and Medical Research.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts